- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-12-01-2020
For Investors, ’Tis the Season to be Grateful
December 11, 2020
Finance
40
12
Vaccine strides, likely pricing impasse point to optimism for 2021.
Assessing the Unexpected: The Unintended Consequences of COVID on Therapeutics
December 11, 2020
Features
40
12
How the pandemic’s impact on physicians and patients has spurred fundamental changes and redefined approaches in areas such as adherence and drug formulation and delivery.
A ‘Sign’ of the Times: Digital Contract Transformation
December 11, 2020
Features
40
12
The pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.
Opening Digital Doors: Remote Selling During COVID-19
December 11, 2020
Features
40
12
Adoption of digital by biopharma reps has added an element of flexibility to their engagement strategies, resulting in better communications with HCPs.
The C-Suite’s Frontline Workers in Digital Change
December 11, 2020
Back Page
40
12
How the CIO role has transformed and strengthened against the backdrop of COVID-19.
Guiding Advice for Leaders Through COVID and Beyond
December 11, 2020
Leadership
40
12
A look at the leadership themes that have resonated most in 2020.
EU Under Pressure to Make Decisions on Data Sharing
December 11, 2020
Global Report
40
12
Must find common ground between digitalization and protection laws.
COVID and AMR: Crisis Reframes Antibiotics Fight
December 11, 2020
Features
40
12
The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Here’s to Looking Ahead
December 11, 2020
From the Editor
40
12
2020 has proven to be a year like no other for pharma. Here is a quick look back at some of the trends 2020 created for the industry.
Philanthropy vs. Innovation - Current Vaccine Prices: Is There a Downside?
December 11, 2020
Features
40
12
Amid COVID-19, pressure for “socially responsible” pricing could temper investments in future urgent healthcare needs.
2020: A Year of Crises, Challenges for FDA & Industry
December 11, 2020
Washington Report
40
12
Pandemic requires innovative R&D and regulatory flexibility to generate critical vaccines and therapies.
Biopharma Joins Race to Net-Zero Carbon Emissions
December 11, 2020
Sustainability
40
12
Why major companies are stepping up environmental commitments.
Pharmaceutical Executive, December 2020 Issue (PDF)
December 11, 2020
Issue PDF
40
12
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Diversity of Thought in Action
December 11, 2020
Executive Profile
40
12
Samit Hirawat, chief medical officer at Bristol Myers Squibb, talks about his leading role in BMS’ $300M, five-year plan to expand its efforts in health equity and his career-long commitment to putting patients first.
The Emergence of Genomics 2.0: Advancing with Data
December 11, 2020
Technology
40
12
To realize the promise of genomics, pharma must be prepared to mine the data more effectively.
Real-World Evidence: State-of-the-Art, Current Challenges and Future Vision
November 30, 2020
40
12
Recent roundtable brought together by Pharm Exec and Parexel features insights from leaders in the pharma industry on the current state and future of RWE.